Skip to main content
MSF logo
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
Medicines shouldn’t be a luxury Take action
Get involved
Our campaigns

Latest Press Releases

Latest Press Releases

Veena Panchal lives in Andheri East, a crowded suburb of Mumbai, along with her two children. She found out in 2002 that she was HIV positive, after the death of her husband from HIV/AIDS. Her two children are HIV negative. Photograph by Subodh Pakhare
Press release
Press release |
10 February 2016
HIV/AIDS
India

Pharma company Viiv’s attempt to secure patents for key HIV drugs dolutegravir and cabotegravir opposed in India

5 min
Metro advertisements for Doctors Without Borders, 2015 Photograph by Drew Angerer
Press release
Press release |
02 February 2016
Intellectual property and trade
New Zealand

There’s still time to stop the TPP from cutting off the critical lifeline of affordable generic medicines

In the laboratory of Maradi, a team of a dozen people receive about 1,200 specimens (blood, urine/stool, mothers' breast milk...) every week, to be analyzed for the trial. The specimens taken in the morning, whether by the medical teams at the five health centres involved in the study or by the field workers or assistant nurses at the patients' homes, arrive at the laboratory in Maradi in the early afternoon. Photograph by Séverine Bonnet Photograph by Séverine Bonnet
Press release
Press release |
01 February 2016
Vaccines

Pfizer attempts to mislead public over research and development ‘facts’ with Tube ads

Tents and debris litter the site of a the refugee camp in Grande Synthe near Dunkirk in northern France. Some 2,500 refugees have settled here whilst they attempt to cross to the United Kingdom to seek asylum. Grande Synthe, Dunkirk: A Gill visits the refugee camps of Calais and Grande Synthe in Dunkirk. Photograph by Jon Levy Photograph by Jon Levy
Press release
Press release |
29 January 2016
Vaccines
France

France: Measles vaccination campaign launched in Calais and Grande-Synthe camps

rVSV-EBOV experimental vaccine against Ebola. Photograph by Yann Libessart Photo credit: Yann Libessart/MSF
Press release
Press release |
20 January 2016
Vaccines

MSF reaction to announcement of Merck and Gavi, the Vaccine Alliance for future Ebola outbreak preparedness

2 min
PEP Drugs for children at Angau Memorial General Hospital, Lae/ Morobe Province in Papua New Guinea. The MSF Family Support Centre provides medical and psychological services for survivors of child abuse, sexual and intimate partner violence. MSF started providing care at the centre in November 2007. Photograph by Fiona Morris
Press release
Press release |
18 January 2016
Intellectual property and trade
European UnionIndia

As EU-India free trade talks get closer to resuming, MSF warns access to medicines under threat

Metro advertisements for Doctors Without Borders, 2015 Photograph by Drew Angerer
Press release
Press release |
15 January 2016
Intellectual property and trade

Response by Jason Cone, MSF-USA Executive Director, to President Obama’s State of the Union Address

2 min
Press release |
14 January 2016
Tropical & neglected diseases
GuineaLiberiaSierra Leone

End of Ebola outbreak in West Africa: World must learn lesson for future outbreaks, says MSF

  • Load More
Navigate
  • About MSF Access
  • Contact us
  • Get involved
  • Our work
  • Resources
  • Search
Get updates
  • Sign up for our newsletter
  • Privacy & data protection information
Contact

MSF Access
Médecins Sans Frontières
140 Route de Ferney
1202 Geneva, Switzerland
Phone:+41 22 849 8484
E-mail: [email protected]

Follow us

  • X
  • Facebook
  • YouTube
  • Medium
Medicines Shouldn't Be A Luxury